GGrantIndex
Sort

172,184 grants matching inflammation

Predictive Models of Beryllium Sensitization and Chronic Beryllium Disease

$2,413,505
Li Li · National Jewish Health · R01 · FY2023 · ES

Collaborative Pediatric Critical Care Research Network

$2,413,174
Jonathan Michael Dean · University Of Utah · PL1 · FY2021 · HD

The Role of Inflammation in Cardiovascular Disease

$2,413,071
David G Harrison · Vanderbilt University Medical Center · P01 · FY2019 · HL

The Role of Inflammation in Cardiovascular Disease

$2,413,071
David G Harrison · Vanderbilt University Medical Center · P01 · FY2020 · HL

The Role of Inflammation in Cardiovascular Disease

$2,413,071
David G Harrison · Vanderbilt University Medical Center · P01 · FY2017 · HL

The Role of Inflammation in Cardiovascular Disease

$2,413,071
David G Harrison · Vanderbilt University Medical Center · P01 · FY2018 · HL

Collaborative Pediatric Critical Care Research Network

$2,412,756
Jonathan Michael Dean · University Of Utah · PL1 · FY2022 · HD

Collaborative Pediatric Critical Care Research Network

$2,412,756
Kevin M Watt · University Of Utah · PL1 · FY2023 · HD

Regulation of pulmonary inflammation by leukocytes and extracellular matrix

$2,412,695
Steven F Ziegler · Benaroya Research Inst At Virginia Mason · P01 · FY2010 · HL

Genetics, Pathophysiology, and Treatment of Dominant Autoinflammatory Diseases

$2,412,663
Daniel Kastner · National Human Genome Research Institute · ZIA · FY2022 · HG

The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury

$2,411,680
Stavros Garantziotis · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES

Interdisciplinary research in vascular biology

$2,411,133
Rodger Paul McEver · Oklahoma Medical Research Foundation · P20 · FY2013 · GM

Utility of Random Biopsies in Inflammatory Bowel Disease

$2,410,980
James D Lewis · University Of Pennsylvania · U01 · FY2024 · DK

Role of mitochondria in neurodegenerative diseases

$2,410,971
Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS

Young Women With Acute Myocardial Infarction

$2,410,890
Harlan M Krumholz · Yale University · R01 · FY2008 · HL

Macrophage Dysfunction in Obesity, Diabetes and Atherosclerosis

$2,410,830
Edward A Fisher · New York University School Of Medicine · P01 · FY2018 · HL

GEARs Combining advances in Genomics and Environmental science to accelerate Actionable Research and practice in ASD

$2,410,823
Heather E Volk · Johns Hopkins University · R01 · FY2022 · ES

Allergic sensitization through the airway

$2,410,231
Donald N Cook · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES

Competing Renewal P01

$2,410,195
Vishwa Deep Dixit · Yale University · P01 · FY2025 · AG

Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities

$2,409,769
Roberta A. Gottlieb · Cedars-Sinai Medical Center · P01 · FY2014 · HL

Macrophage Dysfunction in Obesity, Diabetes and Atherosclerosis

$2,409,733
Edward A Fisher · New York University School Of Medicine · P01 · FY2021 · HL

Scientific innovation for personalized severe asthma management

$2,409,373
Benjamin M Gaston · Indiana University Indianapolis · P01 · FY2022 · HL

Barrett's Esophagus: Predictors of Progression

$2,409,239
Brian J Reid · Fred Hutchinson Cancer Research Center · P01 · FY2011 · CA

EXERCISE TRAIL

$2,408,646
Laura D. Baker · University Of California, San Diego · U19 · FY2014 · AG

Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.

$2,408,617
Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2023 · AG